1 to 9 of 35 results

Sigma files suit to market generic version of Wyeth's Efexor


Australia's Sigma Pharmaceuticals has filed a law suit against Wyeth, in order to get its generic version…

EffexorEffexor XRPfizervenlafaxineVenlafaxine Hydrochloride Extended-ReleaseWyeth

Mylan gets US appro for generic Effexor


USA-based generics giant Mylan has received tentative approval from the Food and Drug Administration…

EffexorEffexor XRvenlafaxineVenlafaxine Hydrochloride Extended-ReleaseWyeth

Wyeth and Impax reach Effexor accord


Health care major Wyeth and fellow USA-based Impax Laboratories say that all conditions of a settlement…

EffexorEffexor XRvenlafaxineVenlafaxine Hydrochloride Extended-ReleaseWyeth

Lexapro will lose ground to amibegron in major depression


Forest Pharmaceuticals' Lexapro (escitalopram) will lose patient share to Sanofi-Aventis' amibegron for…

Aventis PharmaEffexorEffexor XREscitalopram OxalateLexaproSanofi-AventisvenlafaxineVenlafaxine Hydrochloride Extended-ReleaseWyeth

Wyeth moves into profit but disapoints


US health care major Wyeth has reported a swing to a $731.7 million profit, or $0.54 per share, for the...

AmgenEffexorEffexor XREnbreletanerceptPantoprazolePneumococcal 7-valent ConjugatePrevnarProtonixvenlafaxineVenlafaxine Hydrochloride Extended-ReleaseWyeth

Wyeth launches Effexor patient support campaign


US drug major Wyeth has launched a unique education and support program on the domestic market to help…

EffexorEffexor XRvenlafaxineVenlafaxine Hydrochloride Extended-ReleaseWyeth

1 to 9 of 35 results

Back to top